Suchergebnisse - Canan Alhan

Validation of the diagnostic potential of 17 immunophenotypic core markers defined by the ELN‐iMDS‐Flow Working Group in an independent cohort of patients with MDS von Coen R. Veenstra, Canan Alhan, Theresia M. Westers, Arjan A. van de Loosdrecht

Volltext

Development of Machine‐Assisted, Human‐Centred Bone Marrow Cell Classification: Feasibility Analysis in Patients With Myelodysplastic Syndromes von Kiyoyuki Ogata, Yuto Mochimaru, Leonie Saft, Gerrit Sijm, Bouchra Badaoui, Canan Alhan, Carole Almire, Yosuke Kato, Daisuke Sakamoto, Naoko Chiba, Naho Murata, Nana Kasai, Kazuma Sei, Naoya Kawahara, Mika Ogata, Nicolas Chapuis, Orianne Wagner‐Ballon, Arjan van de Loosdrecht, Yumi Yamamoto

Volltext

Prognostic value of measurable residual disease in high‐risk MDS after intensive chemotherapy in HOVON‐SAKK studies von Coen R. Veenstra, Lok Lam Ngai, Patrycja Gradowska, Jurjen Versluis, Tom Reuvekamp, Angèle Kelder, Willemijn Scholten, Sander Snel, Jesse M. Tettero, Costa Bachas, Dimitri A. Breems, Thomas Fischer, Bjørn T. Gjertsen, Laimonas Griskevicius, Gunnar Juliusson, Johan A. Maertens, Markus G. Manz, Thomas Pabst, Jakob R. Passweg, Kimmo Porkka, Canan Alhan, Theresia M. Westers, David C. de Leeuw, Bob Löwenberg, Gert J. Ossenkoppele, Jacqueline Cloos, Arjan A. van de Loosdrecht

Volltext